<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Brinson Patrick</title>
	<atom:link href="http://www.brinsonpatrick.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.brinsonpatrick.com</link>
	<description>Control Over the Capital Raising Process</description>
	<lastBuildDate>Mon, 13 Jul 2015 20:15:24 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Life Sciences Companies Raise over $400mm with ATM Offerings in 2012</title>
		<link>http://www.brinsonpatrick.com/life-science-companies-raise-over-400mm-with-atm-offerings-in-2012/</link>
		<comments>http://www.brinsonpatrick.com/life-science-companies-raise-over-400mm-with-atm-offerings-in-2012/#comments</comments>
		<pubDate>Thu, 25 Apr 2013 13:36:08 +0000</pubDate>
		<dc:creator>Brinson</dc:creator>
				<category><![CDATA[At-the-market (ATM)]]></category>
		<category><![CDATA[Biotech / Life Sciences]]></category>
		<category><![CDATA[News]]></category>

		<guid isPermaLink="false">http://www.brinsonpatrick.com/?p=2339</guid>
		<description><![CDATA[Life sciences companies in the U.S. raised roughly $404 million through ATMs in 2012, compared to $227 million in 2011, a 78 percent year-over-year increase. In the fourth quarter of 2012, life sciences companies raised $128 million through ATMs, compared to $101 million in the third quarter, a 27 percent increase. This ATM activity included <a href='http://www.brinsonpatrick.com/life-science-companies-raise-over-400mm-with-atm-offerings-in-2012/' class='excerpt-more'>[...]</a>]]></description>
		<wfw:commentRss>http://www.brinsonpatrick.com/life-science-companies-raise-over-400mm-with-atm-offerings-in-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ATM Offerings and Equity Lines: Three Differences Issuers Need to Understand</title>
		<link>http://www.brinsonpatrick.com/atm-offerings-and-equity-lines-three-differences-issuers-need-to-understand/</link>
		<comments>http://www.brinsonpatrick.com/atm-offerings-and-equity-lines-three-differences-issuers-need-to-understand/#comments</comments>
		<pubDate>Wed, 20 Feb 2013 13:59:50 +0000</pubDate>
		<dc:creator>Brinson</dc:creator>
				<category><![CDATA[At-the-market (ATM)]]></category>
		<category><![CDATA[Biotech / Life Sciences]]></category>
		<category><![CDATA[Equity Lines]]></category>
		<category><![CDATA[Press Release]]></category>

		<guid isPermaLink="false">http://www.brinsonpatrick.com/?p=2296</guid>
		<description><![CDATA[Todd Wyche was recently featured in Growth Capital Investor highlighting the differences between ATM offerings and equity lines. The three primary differences that the article focused on were the conditions to use the facilities, the method for determining the sales prices of the stock, and the upfront warrants or commitment shares. To read the full <a href='http://www.brinsonpatrick.com/atm-offerings-and-equity-lines-three-differences-issuers-need-to-understand/' class='excerpt-more'>[...]</a>]]></description>
		<wfw:commentRss>http://www.brinsonpatrick.com/atm-offerings-and-equity-lines-three-differences-issuers-need-to-understand/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Brinson Patrick team starts 2013 in San Francisco</title>
		<link>http://www.brinsonpatrick.com/brinson-patrick-team-starts-2013-in-san-francisco/</link>
		<comments>http://www.brinsonpatrick.com/brinson-patrick-team-starts-2013-in-san-francisco/#comments</comments>
		<pubDate>Tue, 15 Jan 2013 21:50:35 +0000</pubDate>
		<dc:creator>Brinson</dc:creator>
				<category><![CDATA[Biotech / Life Sciences]]></category>
		<category><![CDATA[Events]]></category>

		<guid isPermaLink="false">http://www.brinsonpatrick.com/?p=2271</guid>
		<description><![CDATA[It was an action packed week in San Francisco for the Brinson Patrick team, filled with meetings and networking with healthcare professionals attending the JP Morgan Healthcare Conference and Biotech Showcase. Members of our investment banking team in attendance included Todd Wyche and Kevin Tyler. Also participating were research analysts Michael Higgins and Vernon Bernardino. <a href='http://www.brinsonpatrick.com/brinson-patrick-team-starts-2013-in-san-francisco/' class='excerpt-more'>[...]</a>]]></description>
		<wfw:commentRss>http://www.brinsonpatrick.com/brinson-patrick-team-starts-2013-in-san-francisco/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Minimal stock price change following at-the-market (ATM) offering deal announcements</title>
		<link>http://www.brinsonpatrick.com/stock-price-change-following-at-the-market-atm-offering/</link>
		<comments>http://www.brinsonpatrick.com/stock-price-change-following-at-the-market-atm-offering/#comments</comments>
		<pubDate>Mon, 17 Dec 2012 16:19:56 +0000</pubDate>
		<dc:creator>Brinson</dc:creator>
				<category><![CDATA[At-the-market (ATM)]]></category>
		<category><![CDATA[Biotech / Life Sciences]]></category>

		<guid isPermaLink="false">http://www.brinsonpatrick.com/?p=2216</guid>
		<description><![CDATA[At-the-market (ATM) offerings continue to show strong growth in the life sciences industry, with 29 agreements signed in 2012, compared to 18 agreements in 2011. Not only is it clear that companies are recognizing the benefits of accessing capital at a lower cost through the use of ATMs, there is also data that supports stock <a href='http://www.brinsonpatrick.com/stock-price-change-following-at-the-market-atm-offering/' class='excerpt-more'>[...]</a>]]></description>
		<wfw:commentRss>http://www.brinsonpatrick.com/stock-price-change-following-at-the-market-atm-offering/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dark Pools &amp; At-the-Market Offerings</title>
		<link>http://www.brinsonpatrick.com/dark-pools-at-the-market-offerings/</link>
		<comments>http://www.brinsonpatrick.com/dark-pools-at-the-market-offerings/#comments</comments>
		<pubDate>Fri, 30 Nov 2012 16:11:11 +0000</pubDate>
		<dc:creator>Brinson</dc:creator>
				<category><![CDATA[At-the-market (ATM)]]></category>
		<category><![CDATA[Trading]]></category>
		<category><![CDATA[at-the-market (ATM)]]></category>
		<category><![CDATA[at-the-market offerings]]></category>
		<category><![CDATA[atm offerings]]></category>
		<category><![CDATA[HFT]]></category>
		<category><![CDATA[trading]]></category>

		<guid isPermaLink="false">http://www.brinsonpatrick.com/?p=2138</guid>
		<description><![CDATA[Dark pools of liquidity (dark pools) play a vital function in the equity marketplace and using them has become standard operating procedure, especially when executing large trades.  Unlike  traditional exchanges, dark pools provide market participants with trading venues where quotes (price, size, and side of an order) are not displayed. This in turn allows market <a href='http://www.brinsonpatrick.com/dark-pools-at-the-market-offerings/' class='excerpt-more'>[...]</a>]]></description>
		<wfw:commentRss>http://www.brinsonpatrick.com/dark-pools-at-the-market-offerings/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>3Q 2012 Starts with ATMs in the News</title>
		<link>http://www.brinsonpatrick.com/3q-2012-starts-with-atms-in-the-news/</link>
		<comments>http://www.brinsonpatrick.com/3q-2012-starts-with-atms-in-the-news/#comments</comments>
		<pubDate>Thu, 25 Oct 2012 14:21:34 +0000</pubDate>
		<dc:creator>Brinson</dc:creator>
				<category><![CDATA[At-the-market (ATM)]]></category>
		<category><![CDATA[Biotech / Life Sciences]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[at-the-market (ATM)]]></category>
		<category><![CDATA[at-the-market offerings]]></category>
		<category><![CDATA[atm offerings]]></category>

		<guid isPermaLink="false">http://www.brinsonpatrick.com/?p=2022</guid>
		<description><![CDATA[On October 1, we kicked off the third quarter with the publication of two news articles featuring Todd Wyche, CEO of Brinson Patrick. The first, published by Growth Capital Investor, provides insights into the recent surge of interest in ATM offerings. The published article, which can be viewed online here, describes the growth in use <a href='http://www.brinsonpatrick.com/3q-2012-starts-with-atms-in-the-news/' class='excerpt-more'>[...]</a>]]></description>
		<wfw:commentRss>http://www.brinsonpatrick.com/3q-2012-starts-with-atms-in-the-news/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Effects of High Frequency Trading on Raising Capital</title>
		<link>http://www.brinsonpatrick.com/throttling-high-frequency-trading/</link>
		<comments>http://www.brinsonpatrick.com/throttling-high-frequency-trading/#comments</comments>
		<pubDate>Tue, 23 Oct 2012 16:31:12 +0000</pubDate>
		<dc:creator>Brinson</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.brinsonpatrick.com/?p=2009</guid>
		<description><![CDATA[High frequency trading (HFT) has come to dominate trading in US stocks over the last decade.  Decimalization and Reg NMS has helped foster the growth of sophisticated computer programs that today buy and sell stock in a blink of an eye.   In general, HFT has contributed to increased efficiencies to the equity markets through increased <a href='http://www.brinsonpatrick.com/throttling-high-frequency-trading/' class='excerpt-more'>[...]</a>]]></description>
		<wfw:commentRss>http://www.brinsonpatrick.com/throttling-high-frequency-trading/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ATM offerings provide the lowest cost of capital for life sciences issuers &#187;</title>
		<link>http://www.brinsonpatrick.com/atm-offerings-provide-lowest-cost-of-capital-for-life-sciences-issuers/</link>
		<comments>http://www.brinsonpatrick.com/atm-offerings-provide-lowest-cost-of-capital-for-life-sciences-issuers/#comments</comments>
		<pubDate>Tue, 25 Sep 2012 18:51:15 +0000</pubDate>
		<dc:creator>kclark</dc:creator>
				<category><![CDATA[At-the-market (ATM)]]></category>
		<category><![CDATA[Biotech / Life Sciences]]></category>
		<category><![CDATA[at-the-market offerings]]></category>
		<category><![CDATA[atm offerings]]></category>
		<category><![CDATA[life sciences equity capital]]></category>

		<guid isPermaLink="false">http://www.brinsonpatrick.com/?p=1765</guid>
		<description><![CDATA[As we’ve said before, and throughout our website, for publicly traded life sciences companies, having at-the-market financing in the toolkit just makes sense. ATMs deliver control over the timing and amount of stock that reaches the market, giving life sciences organizations the flexibility to fund a clinical trial, make leveraged investments, ride the waves of <a href='http://www.brinsonpatrick.com/atm-offerings-provide-lowest-cost-of-capital-for-life-sciences-issuers/' class='excerpt-more'>[...]</a>]]></description>
		<wfw:commentRss>http://www.brinsonpatrick.com/atm-offerings-provide-lowest-cost-of-capital-for-life-sciences-issuers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Brinson Patrick co-sponsors BioCentury’s NewsMakers in the Biotech Industry Conference &#187;</title>
		<link>http://www.brinsonpatrick.com/biotech-industry-conference-september2012/</link>
		<comments>http://www.brinsonpatrick.com/biotech-industry-conference-september2012/#comments</comments>
		<pubDate>Fri, 14 Sep 2012 00:00:54 +0000</pubDate>
		<dc:creator>kclark</dc:creator>
				<category><![CDATA[BioCentury]]></category>
		<category><![CDATA[Biotech / Life Sciences]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[biotech conference]]></category>
		<category><![CDATA[life sciences industry]]></category>

		<guid isPermaLink="false">http://www.brinsonpatrick.com/?p=1722</guid>
		<description><![CDATA[Members of our investment banking team &#8211; Todd Wyche, Kevin Tyler and Rada Milenovici attended the BioCentury NewsMakers Conference in New York earlier this month. Also in attendance were members of our research team &#8211; Vernon Bernardino and Michael Higgins. The conference featured companies with major product and earnings events that are expected to play <a href='http://www.brinsonpatrick.com/biotech-industry-conference-september2012/' class='excerpt-more'>[...]</a>]]></description>
		<wfw:commentRss>http://www.brinsonpatrick.com/biotech-industry-conference-september2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Trendwatch: Technology companies convert to REITs &#187;</title>
		<link>http://www.brinsonpatrick.com/trendwatch-technology-companies-convert-to-reits/</link>
		<comments>http://www.brinsonpatrick.com/trendwatch-technology-companies-convert-to-reits/#comments</comments>
		<pubDate>Thu, 13 Sep 2012 23:12:27 +0000</pubDate>
		<dc:creator>Brinson</dc:creator>
				<category><![CDATA[REITs]]></category>

		<guid isPermaLink="false">http://03622d5.netsolhost.com//wordpress/?p=1</guid>
		<description><![CDATA[Even as the real estate watchers continue to monitor signs of industry recovery, tech companies with large real estate assets are increasingly turning to a REIT structure to reduce their tax burden. It’s good news for investors too, as REITs are required to distribute a minimum of 90% of profits as dividends. Recent news that <a href='http://www.brinsonpatrick.com/trendwatch-technology-companies-convert-to-reits/' class='excerpt-more'>[...]</a>]]></description>
		<wfw:commentRss>http://www.brinsonpatrick.com/trendwatch-technology-companies-convert-to-reits/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
